(Q38766010)

6 September 2017

title

Systematic review of red yeast rice compared with simvastatin in dyslipidaemia (English)

1 reference

6 September 2017

1 reference

1 reference

1 reference

Yi Chin Ong

1

1 reference

6 September 2017

Zoriah Aziz

series ordinal

2

1 reference

6 September 2017

publication date

9 March 2016

1 reference

Journal of Clinical Pharmacy and Therapeutics

6 September 2017

published in

1 reference

6 September 2017

volume

41

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

170-179

1 reference

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Statin myopathy: a common dilemma not reflected in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Red yeast rice: a new hypolipidemic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Clinically relevant differences between the statins: implications for therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12374

21 January 2018

Identifiers

DOI

10.1111/JCPT.12374

1 reference

6 September 2017

1 reference